fostemsavir (Rukobia)
1 February 2021. Related: ARVs and PrEP, Entry inhibitors

1 February 2021. Related: ARVs and PrEP, Entry inhibitors

22 March 2023. Related: ARVs and PrEP, Entry inhibitors, monoclonal antibody (mAb)

Ibalizumab is a 200 mg concentrate that is then made up as an infusion.
1 April 2013. Related: ARVs and PrEP, CCR5 inhibitors, Entry inhibitors

26 August 2012. Related: ARVs and PrEP, Entry inhibitors, Fusion inhibitors
![]()